NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) Sees Large Increase in Short Interest

NRx Pharmaceuticals, Inc. (NASDAQ:NRXPWGet Free Report) was the target of a large growth in short interest in November. As of November 30th, there was short interest totalling 3,900 shares, a growth of 225.0% from the November 15th total of 1,200 shares. Based on an average trading volume of 4,900 shares, the days-to-cover ratio is currently 0.8 days.

NRx Pharmaceuticals Trading Up 13.0 %

Shares of NASDAQ:NRXPW traded up $0.01 during midday trading on Thursday, reaching $0.07. 1,321 shares of the company’s stock traded hands, compared to its average volume of 15,634. NRx Pharmaceuticals has a one year low of $0.04 and a one year high of $0.39. The stock has a 50 day moving average of $0.06 and a 200 day moving average of $0.07.

About NRx Pharmaceuticals

(Get Free Report)

NRx Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned FDA-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior.

See Also

Receive News & Ratings for NRx Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NRx Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.